Showing results (101-110 of 120) with videos related to
Sort By:
Pageof 12
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2024
Five-year analysis of neoadjuvant dabrafenib and trametinib for stage III melanomaA M Menzies, S N Lo, R P M Saw, et al.The Journal of Investigative Dermatology|February 18, 2019
Molecular Genomic Profiling of Melanocytic NeviAndrew J Colebatch, Peter Ferguson, Felicity Newell, et al.Annals of Surgical Oncology|August 4, 2021
Survival Outcomes of Salvage Metastasectomy After Failure of Modern-Era Systemic Therapy for MelanomaAndrew T Li, Kavita Vakharia, Serigne N Lo, et al.Journal of the National Cancer Institute|June 15, 2026
Utility of recurrence-based surrogate endpoints for survival in adjuvant cancer trials: evidence from melanomaSophie E Orme, Serigne N Lo, Robyn P Saw, et al.Annals of Surgical Oncology|May 18, 2024
The Effect of Neoadjuvant Systemic Therapy on Surgical Outcomes After Lymph Node Dissections for Stage III Melanoma; An Australian CohortLisanne P Zijlker, Henry Chen, Andrew J Spillane, et al.Cell Reports|June 30, 2024
Single-cell spatial multiomics reveals tumor microenvironment vulnerabilities in cancer resistance to immunotherapyCamelia Quek, Aditya Pratapa, Xinyu Bai, et al.The Lancet. Oncology|June 8, 2019
Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB-C, BRAFV600 mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trialGeorgina V Long, Robyn P M Saw, Serigne Lo, et al.Journal of Translational Medicine|September 5, 2022
Higher polygenic risk for melanoma is associated with improved survival in a high ultraviolet radiation settingMathias Seviiri, Richard A Scolyer, D Timothy Bishop, et al.European Journal of Cancer (Oxford, England : 1990)|June 14, 2021
Re-defining the role of surgery in the management of patients with oligometastatic stage IV melanoma in the era of effective systemic therapiesSydney Ch'ng, Semra Uyulmaz, Matteo S Carlino, et al.Human Molecular Genetics|July 28, 2020
Multiplex melanoma families are enriched for polygenic riskMatthew H Law, Lauren G Aoude, David L Duffy, et al.Pageof 12